@inproceedings{fdi:010095776,
  title = {{T}he added value of using of pulse oximeter into the integrated management of childhood illness guidelines to better identify and manage severe cases among children under-5 years old in west africa, june 2021 to june 2022 [r{\'e}sum{\'e}]},
  author = {{H}edible, {G}. and {N}eboua, {D}. and {P}eters-{B}okol, {L}. and {Z}air, {Z}. and {G}uaniyi, {A}. and {L}ouart, {S}. and {R}idde, {V}al{\'e}ry and {A}nago, {G}. and {L}enaud, {S}. and {A}gbeci, {H}. and {K}argougou, {D}. and {M}eda, {B}. and {K}oli{\'e}, {J}. and {L}eroy, {V}.},
  editor = {},
  language = {{ENG}},
  abstract = {{B}ackground: {T}he {I}ntegrated {M}anagement of {C}hildhood {I}llness ({IMCI}) guidelines for children under 5 is a symptom-based algorithm guiding health care workers in resource-limited countries at the primary health center ({PHC}) level. {H}ypoxaemia ({S}p{O}2< 90%) is a life-threatening condition underdiagnosed in {W}est {A}frica. {T}o improve the diagnosis and care-management of hypoxaemia, the {AIRE} project, {UNITAID}-funded, has implemented the routine {P}ulse {O}ximeter use into {IMCI} consultations at {PHC}s level in {B}urkina {F}aso, {G}uinea, {M}ali and {N}iger. {T}his study aimed to measure the added value of {PO} integrated into {IMCI}. {M}ethods: {I}n 16 {AIRE} research {PHC}s (4/country), all children aged 0-59 months attending {IMCI} consultations, except those aged 2-59 months classified as green non-respiratory cases were eligible for {PO} use, and enrolled in a cross-sectional study with parent's consent. {T}hose classified as severe cases were followed for 14 days. {S}ocio-demographic and clinical data including data about {PO} use, pathways, patterns of care and health outcomes at {D}14 were collected. {R}esults: {F}rom {J}une 2021 to {J}une 2022, 39,496 children attended {IMCI} consultations; 31,721 were eligible for {PO} use of whom 80.3% had an {S}p{O}2 measurement. {T}he prevalence of severe case using {IMCI}+{PO} was at 10% (n=3,179; 95% confidence interval [95%{CI}]: 9.7-10.4). {H}ypoxemia prevalence was 0.7%




(95%{CI}: 0.58-0.76) among eligible children for {PO} use and 6.6% (95%{CI}: 5.8- 7.5) among all severe cases. {O}f all severe cases identified with {IMCI}+{PO}, 1,981 were enrolled and followed-up, their {D}-14 mortality rate was 4.8% (95%{CI}: 3.5 -5.3). {T}he {PO} allowed to identify +1.9% (95% {CI}: 1.5 -2.5) severe cases. {C}onclusion: {B}ased on this large sample study, the uptake of {PO} integrated into {IMCI} consultations was high and the identification of severe cases have been increased for +1.9% using {PO}. {H}owever, hospital referral and timely oxygen therapy to manage them remain challenges for governments in the {W}est {A}frican settings.},
  keywords = {{BURKINA} {FASO} ; {GUINEE} ; {MALI} ; {NIGER}},
  volume = {5 ({S}uppl.)},
  numero = {},
  pages = {{A}1147 (1 )},
  booktitle = {},
  year = {2023},
  DOI = {10.18332/popmed/164570},
  ISSN = {2654-1459},
  URL = {https://www.documentation.ird.fr/hor/fdi:010095776},
}